Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

相关概念视频

Recombinant DNA

Recombinant DNA

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Targeting TNFR1 by salvianolic acid B alleviates sepsis-induced acute lung injury and pulmonary-intestinal epithelial barrier damage.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026

Same author

Effective Doses and Predictors of Dexmedetomidine for Inducing Specific Sleep Stages (N2/N3) in Chronic Insomnia: A Retrospective Cohort Study.

Nature and science of sleep·2026

Same author

Rapid assembly of fluorescence enhanced plasmonic dimers for intracellular single-particle imaging.

Nanoscale·2026

Same author

Case Report: A giant uterine leiomyoma with pseudo-Meigs syndrome combined with a triad of umbilical hernia-prolapse-thrombosis.

Frontiers in reproductive health·2026

Same author

Permeable nanoreactor eye drop for enzymatic cascade-mediated treatment for acute retinal injury model mimicking geographic atrophy.

Nature communications·2026

Same author

m<sup>6</sup>preQ<sub>0</sub> reduces oxidative stress and alleviates glucose-induced lipid accumulation via insulin/IGF-1 signaling pathway in C. elegans.

Biochemical and biophysical research communications·2026

Search research articles

相关实验视频

Updated: Jan 15, 2026

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

再组合的人类mitsugumin 53:一种潜在的治疗药物,用于多种疾病.

Junfeng Li¹, Jingjing Shen², Tian Li^3,4,5,6

¹Department of Oncology of Zaozhuang Hospital of Zaozhuang Mining Group, Zaozhuang, Shandong, China.

Frontiers in pharmacology

|October 8, 2025

概括

三重53 (MG53) 蛋白质有助于肌肉的修复,并保护器官免受伤害. 重组人类MG53 (rhMG53) 在各种疾病中显示出治疗潜力,包括心血管和多器官损伤.

关键词:

肺部急性肺损伤是什么心血管疾病心血管疾病造成脏损伤的人.再组合的人类MG53 MG53 瘤是一个瘤.

更多相关视频

Stability and Structure of Bat Major Histocompatibility Complex Class I with Heterologous β2-Microglobulin

Stability and Structure of Bat Major Histocompatibility Complex Class I with Heterologous β2-Microglobulin

Published on: March 10, 2021

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Published on: October 3, 2011

相关实验视频

Last Updated: Jan 15, 2026

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

Stability and Structure of Bat Major Histocompatibility Complex Class I with Heterologous β2-Microglobulin

Stability and Structure of Bat Major Histocompatibility Complex Class I with Heterologous β2-Microglobulin

Published on: March 10, 2021

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Published on: October 3, 2011

科学领域:

生物化学生化学
分子生物学分子生物学
再生医学是一种再生医学.

背景情况:

三古53 (MG53) 是一种肌肉表达的蛋白质,对囊膜修复至关重要.
MG53还在非条纹组织中发挥作用,如肺,和免疫细胞.
内生MG53在心脏缺血/再输液损伤中起着保护作用.

研究的目的:

审查复合人类MG53 (rhMG53) 的治疗功能.
阐明rhMG53在多器官损伤中的保护作用背后的分子机制.
为突出rhMG53作为治疗各种疾病的治疗剂的潜力.

主要方法:

关于MG53和rhMG53的研究文献综述.
在各种疾病模型中分析分子机制.
对rhMG53广泛的治疗应用的证据综合.

主要成果:

rhMG53在骨肌损伤模型中显示出保护作用.
rhMG53在心血管疾病和多器官损伤环境中显示出有效性.
研究证实rhMG53具有广泛的保护能力.

结论:

rhMG53对多个器官损伤具有显著的治疗潜力.
了解rhMG53的机制有助于其作为新型治疗剂的发展.
rhMG53代表了治疗广泛疾病的有希望的候选人.